Peter Fail

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Antithrombotic Therapy for Venous Thromboembolic Disease

EAE/ASE Recommendations for the Use of Echocardiography in New Transcatheter Interventions for Valvular Heart Disease

Recommendations for transoesophageal echocardiography: EACVI update 2014

Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair

Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation

Proportionate and Disproportionate Functional Mitral Regurgitation

Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: Establishing the benchmark against which percutaneous interventions should be judged

Valvular Heart Disease

Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions

One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry

Diabetic Foot Ulcers and Their Recurrence

Mitral valve disease—current management and future challenges

Current and Potential Rodent Screens and Tests for Thyroid Toxicants

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Percutaneous Mitral Valve Interventions in the Real World

A New Method for Aggressive Management of Deep Vein Thrombosis: Retrospective Study of the Power Pulse Technique

Bivalirudin: a review

Presumed Pulmonary Embolism Following Power-Pulse Spray Thrombectomy of Upper Extremity Venous Thrombosis

Predictors of Sleep-Disordered Breathing in Community-Dwelling Adults<subtitle>The Sleep Heart Health Study</subtitle>

Treatment and Prevention of Heparin-Induced Thrombocytopenia

Outcome after hypogastric artery bypass and embolization during endovascular aneurysm repair

Standard Versus Low-Dose Weight-Adjusted Heparin in Patients Treated With the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3 Fab) During Percutaneous Coronary Revascularization

Institutional Experience With Transcatheter Mitral Valve Repair and Clinical Outcomes

4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation

Longitudinal Outcome of Isolated Mitral Repair in Older Patients: Results From 14,604 Procedures Performed From 1991 to 2007

Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement

Discordance Between Echocardiography and MRI in the Assessment of Mitral Regurgitation Severity

The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm

Aptamers as targeted therapeutics: current potential and challenges

Arteriotomy Closure Devices for Cardiovascular Procedures

SCAI/AATS/ACC/STS Operator and Institutional Requirements for Transcatheter Valve Repair and Replacement. Part II. Mitral Valve

Transcatheter Interventions for Mitral Regurgitation

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation

Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis

Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles

Vascular Closure Devices

Correction of Mitral Regurgitation in Nonresponders to Cardiac Resynchronization Therapy by MitraClip Improves Symptoms and Promotes Reverse Remodeling

Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty

Atherosclerosis Inflammation Imaging with ¹⁸F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations

Epidemiology of valvular heart disease in the adult

Percutaneous Mitral Valve Repair for Mitral Regurgitation in High-Risk Patients

Significant Mitral Regurgitation Left Untreated at the Time of Aortic Valve Replacement

Third Universal Definition of Myocardial Infarction

Recommendations for transoesophageal echocardiography: update 2010

Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention

Inflammation in Atherosclerosis

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Survival of Transcatheter Mitral Valve Repair Compared With Surgical and Conservative Treatment in High-Surgical-Risk Patients

Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: An alternative in patients with contraindications to thrombolysis

End-to-end design of wearable sensors

Refining the prognostic impact of functional mitral regurgitation in chronic heart failure

Secondary Mitral Regurgitation in Heart Failure

Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review

Communication About Serious Illness Care Goals

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

One-Year Outcomes After MitraClip for Functional Mitral Regurgitation

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

Analysis of aptamer discovery and technology

Relationship Between the Magnitude of Reduction in Mitral Regurgitation Severity and Left Ventricular and Left Atrial Reverse Remodeling After MitraClip Therapy

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant

2015 ESC Guidelines for the management of infective endocarditis

Decision Making in Advanced Heart Failure

Heart Disease Identification Method Using Machine Learning Classification in E-Healthcare

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Percutaneous Repair or Surgery for Mitral Regurgitation

Novel simultaneous combination chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb ischemia: The power‐pulse spray technique

Safety and efficacy of staple‐mediated femoral arteriotomy closure: Results from a randomized multicenter study

Response of the pituitary and thyroid to tropic hormones in Sprague- Dawley versus Fischer 344 male rats

Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study

Exclusion of an isolated iliac artery aneurysm using a bifurcated endograft following failed covered stent exclusion

Percutaneous Mitral Repair With the MitraClip System

The Acute Hemodynamic Effects of MitraClip Therapy

Midterm Outcomes From the TALON Registry:Treating Peripherals With SilverHawk:Outcomes Collection

Subcutaneous heparin in postangioplasty management: Comparative trial with intravenous heparin

Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions.

Percutaneous Repair or Surgery for Mitral Regurgitation